|
An Open-lable, Multicenter, expanded access study of INC424 for patients with primary myelofibrosis (PMF) or post polycythemia myelofibrosis (PPV MF) or post-essential thrombocythemia myelofibrosis (PET-MF).
|
Ongoing
|
Ruxolitinib
|
3b
|
CINC424A2401
|
King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah)
|
|
A Phase III, Multicenter, Randomized, parallel-group study to asses the efficacy and saftey of double-blind pasireotide LAR 40 mg and pasireotide LAR 60 mg versus open lable octreotide LAR or lanreotide ATG in patients with inadequately controlled acromegaly.
|
Ongoing
|
Pasireotide
|
3
|
CSOM230C2402
|
King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical City NG (Jeddah)
|
|
A Randomized, Open-label, Multicentral, Two Arm, Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)
|
Ongoing
|
Deferasirox / Defearisox new formula
|
2
|
CICL670F2201
|
King Khalid University Hospital (Riyadh), King Fahad University Hospital (Al-Khobar), King Abdulaziz University Hospital (Jeddah), King Fahad Specialist Hospital (Dammam)
|
|
Daily practice treatment and Influence of Visanne on the patient Assessment of quality of life parameters
|
Completed
|
Visanne
|
4
|
VS1101
|
King Khalid University Hospital (Riyadh), Soliman Fakeeh Hospital (Jeddah)
|
|
A 20-week Study Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients Uncontrolled on NPH Insulin
|
Completed
|
BIAsp 30 / Metformin
|
4
|
BIAsp 3968
|
King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz University Hospital (Jeddah), Armed Forces Hospital (Al-Hada)
|
|
An Open-Label, Randomized Naturalistic Study to Evaluate the Incidence of Hypoglycemia Comparing Sitagliptin With Sulfonylurea Treatment in Patients With Type 2 Diabetes During Ramadan Fasting
|
Completed
|
Sitagliptin
|
4
|
MK0431-263
|
Al-Noor Specialist Hospital (Makkah), Armed Forces Hospital (Al-Hada), King Fahad University Hospital (Al-Khobar), Riyadh Care Hospital, Al Alam Medical Center (Riyadh)
|
|
A Multicenter, Prospective, Observational, Non-Interventional Cohort Study Evaluating On-Treatment Predictors of Response in Subjects With HBeAg Positive and HBeAg Negative Chronic Hepatitis B Receiving Therapy With PEGASYS(R) (Peginterferon Alfa-2a 40KD)
|
Completed
|
Pegasys
|
4
|
MV22009
|
King Fahad University Hospital (Al-Khobar), Armed Forces Hospital (Kharj)
|
|
A multicentre, prospective observational cohort study to assess the effects of vildagliptin relative to sulphonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan
|
Completed
|
Vildagliptin / Sulphonylurea / Metformin
|
4
|
CLAF237A-MAX-AE-02
|
Soliman Fakeeh Hospital (Jeddah)
|
|
A double blind, Double Dummy, Randomized, Multi-Centre study to assess the tolerability and Efficacy Profile of Vildagliptin Compared to Gliclazide as Dual Therapy with Metformin in Muslim Patients with Type 2 Diabetes Fasting During Ramadan.
|
Completed
|
Vildagliptin /Gliclazide / Metformin
|
4
|
CLAF237A2411
|
King Fahad University Hospital (Al-Khobar)_ King Abdulaziz Medical City NG (Riyadh)
|
|
UNraveling nAMD real life Clinical management and Outcome with intraVitrEal Ranibizumab injection – A retrospective analysis (UNCOVER)
|
Completed
|
Ranibizumab
|
4
|
CRFB0021
|
King Khaled Eye Specialist Hospital (Riyadh)
|
